RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
60.65
-1.61 (-2.59%)
At close: May 17, 2024, 4:00 PM
60.18
-0.47 (-0.77%)
After-hours: May 17, 2024, 5:02 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $2.36 billion as of May 17, 2024. Its market cap has increased by 216.62% in one year.
Market Cap
2.36B
Enterprise Value
2.24B
1-Year Change
216.62%
Ranking
Category
Stock Price
$60.65
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $2.36B, an increase of 457.08%. That is a compound annual growth rate of 84.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 2.26B | -2.58% |
| May 16, 2024 | 2.32B | -3.16% |
| May 15, 2024 | 2.39B | 6.78% |
| May 14, 2024 | 2.24B | 2.41% |
| May 13, 2024 | 2.19B | -0.87% |
| May 10, 2024 | 2.21B | -3.44% |
| May 9, 2024 | 2.28B | 1.25% |
| May 8, 2024 | 2.26B | -2.46% |
| May 7, 2024 | 2.31B | -1.04% |
| May 6, 2024 | 2.34B | 2.45% |
| May 3, 2024 | 2.28B | 3.44% |
| May 2, 2024 | 2.21B | 5.17% |
| May 1, 2024 | 2.10B | 8.76% |
| Apr 30, 2024 | 1.93B | -2.12% |
| Apr 29, 2024 | 1.97B | 0.93% |
| Apr 26, 2024 | 1.95B | 1.69% |
| Apr 25, 2024 | 1.92B | -1.80% |
| Apr 24, 2024 | 1.95B | -3.79% |
| Apr 23, 2024 | 2.03B | 4.93% |
| Apr 22, 2024 | 1.94B | 1.47% |
| Apr 19, 2024 | 1.91B | -0.33% |
| Apr 18, 2024 | 1.91B | -2.05% |
| Apr 17, 2024 | 1.95B | -2.72% |
| Apr 16, 2024 | 2.01B | 1.97% |
| Apr 15, 2024 | 1.97B | -3.30% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 2.50B |
| Fortrea Holdings | 2.48B |
| ACADIA Pharmaceuticals | 2.45B |
| Janux Therapeutics | 2.44B |
| NovoCure | 2.39B |
| Patterson Companies | 2.32B |
| Indivior | 2.32B |
| Vericel | 2.32B |